Skip to content
healthcare.dev

Lamotrigine Extended-Release

NDC 10370-256, lamotrigine, tablet, film coated, extended release, from Par Health USA, LLC.

Product NDC
10370-256
Status
Listed
Labeler
Par Health USA, LLC
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA201374
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10370-256 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMOTRIGINE300 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
10370-256-111037002561130 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10370-256-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d5ec4d58-c669-4ab4-ba62-b71007536854
  • NADAC price for package 10370025611

    GET /v1/drugs/nadac/10370025611

Use it

Look up 10370-256 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10370-256 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10370-256. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.